secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0000721371-25-000128
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q1 revenue $64B (+22%), non-GAAP EPS $2.55 (+36%); raises FY2026 guidance
--------------------------------------------------------------------------------

- Revenue $64B (+22% YoY); GAAP diluted EPS $1.88 (+11%); non-GAAP diluted EPS $2.55 (+36%).
- Segment profit growth across all five segments; Pharmaceutical & Specialty profit up 26% to $667M.
- FY2026 non-GAAP EPS guidance raised to $9.65-$9.85 (from $9.30-$9.50); adjusted free cash flow raised to $3.0-$3.5B.
- Acquisition of Solaris Health expected to close early November; initiated $375M accelerated share repurchase in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000128/0000721371-25-000128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000128/cah-20251030.htm
  HTML page:      https://secwatch.observer/filing/0000721371-25-000128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer